Diagnosis, Treatment and Prevention of Age-Related Macular Degeneration
In this reprint, we hope to review the basics and highlight the latest developments in AMD. This demonstrates the benefits of the international scientific community working on this disease, to limit its negative impacts, the most vital of which is the loss of visual function, leading to a loss of au...
Gorde:
| Formatua: | Online |
|---|---|
| Hizkuntza: | ingelesa |
| Argitaratua: |
MDPI - Multidisciplinary Digital Publishing Institute
2022
|
| Gaiak: | |
| Sarrera elektronikoa: | ONIX_20220506_9783036539300_71 |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|
| _version_ | 1869524050033770496 |
|---|---|
| collection | Directory of Open Access Books |
| description | In this reprint, we hope to review the basics and highlight the latest developments in AMD. This demonstrates the benefits of the international scientific community working on this disease, to limit its negative impacts, the most vital of which is the loss of visual function, leading to a loss of autonomy and a decrease in patients’ quality of life. |
| format | Online |
| id | doab-20.500.12854ir-81005 |
| institution | Directory of Open Access Books |
| language | eng |
| publishDate | 2022 |
| publishDateRange | 2022 |
| publishDateSort | 2022 |
| publisher | MDPI - Multidisciplinary Digital Publishing Institute |
| publisherStr | MDPI - Multidisciplinary Digital Publishing Institute |
| record_format | ojs |
| spelling | doab-20.500.12854ir-810052024-03-31T13:10:21Z Diagnosis, Treatment and Prevention of Age-Related Macular Degeneration Kodjikian, Laurent aflibercept monotherapy polypoidal choroidal vasculopathy neovascular age-related macular degeneration good baseline visual acuity ForeseeHome AMD Monitoring System® AREDS2-HOME study age-related macular degeneration exudation optical coherence tomography angiography anti-vascular endothelial growth factor brolucizumab epithelial tear optical coherence tomography Sorsby’s fundus dystrophy Sorsby hereditary retinal dystrophy choroidal neovascularisation macular neovascularization anti-VEGF treatment long-term FU treatment outcome emerging treatment neovascular age-related macular degeneration (nAMD) Vascular Endothelial Growth Factor (VEGF) cataract surgery clinical trials real-world evidence AMD oct-angiography fellow eye choriocapillaris quiescent macular neovascularization ranibizumab aflibercept anti-VEGF visual acuity reading acuity disease activity treatment change treat and extend switch therapy retina choroidal neovascularization angiogenesis meteorin therapeutic innovation prevention nutrients lifestyle treatment-naive anti–vascular endothelial growth factor cardiovascular risk factors arterial hypertension macula-off rhegmatogenous detachment superficial perifoveal capillary plexus retinal deep perifoveal capillary plexus identification risk Delphi STARS® food supplement bevacizumab meta-analysis meta-regression n/a age-related macular degeneration (AMD) comparative therapies effectiveness intravitreal anti-vascular endothelial growth factor treat-and-extend pro re nata regimen thema EDItEUR::M Medicine and Nursing In this reprint, we hope to review the basics and highlight the latest developments in AMD. This demonstrates the benefits of the international scientific community working on this disease, to limit its negative impacts, the most vital of which is the loss of visual function, leading to a loss of autonomy and a decrease in patients’ quality of life. 2022-05-06T11:21:10Z 2022-05-06T11:21:10Z 2022 book ONIX_20220506_9783036539300_71 9783036539300 9783036539294 https://directory.doabooks.org/handle/20.500.12854/81005 eng image/jpeg Attribution 4.0 International https://mdpi.com/books/pdfview/book/5347 https://mdpi.com/books/pdfview/book/5347 MDPI - Multidisciplinary Digital Publishing Institute 10.3390/books978-3-0365-3929-4 10.3390/books978-3-0365-3929-4 46cabcaa-dd94-4bfe-87b4-55023c1b36d0 9783036539300 9783036539294 246 Basel open access |
| spellingShingle | aflibercept monotherapy polypoidal choroidal vasculopathy neovascular age-related macular degeneration good baseline visual acuity ForeseeHome AMD Monitoring System® AREDS2-HOME study age-related macular degeneration exudation optical coherence tomography angiography anti-vascular endothelial growth factor brolucizumab epithelial tear optical coherence tomography Sorsby’s fundus dystrophy Sorsby hereditary retinal dystrophy choroidal neovascularisation macular neovascularization anti-VEGF treatment long-term FU treatment outcome emerging treatment neovascular age-related macular degeneration (nAMD) Vascular Endothelial Growth Factor (VEGF) cataract surgery clinical trials real-world evidence AMD oct-angiography fellow eye choriocapillaris quiescent macular neovascularization ranibizumab aflibercept anti-VEGF visual acuity reading acuity disease activity treatment change treat and extend switch therapy retina choroidal neovascularization angiogenesis meteorin therapeutic innovation prevention nutrients lifestyle treatment-naive anti–vascular endothelial growth factor cardiovascular risk factors arterial hypertension macula-off rhegmatogenous detachment superficial perifoveal capillary plexus retinal deep perifoveal capillary plexus identification risk Delphi STARS® food supplement bevacizumab meta-analysis meta-regression n/a age-related macular degeneration (AMD) comparative therapies effectiveness intravitreal anti-vascular endothelial growth factor treat-and-extend pro re nata regimen thema EDItEUR::M Medicine and Nursing Diagnosis, Treatment and Prevention of Age-Related Macular Degeneration |
| title | Diagnosis, Treatment and Prevention of Age-Related Macular Degeneration |
| title_full | Diagnosis, Treatment and Prevention of Age-Related Macular Degeneration |
| title_fullStr | Diagnosis, Treatment and Prevention of Age-Related Macular Degeneration |
| title_full_unstemmed | Diagnosis, Treatment and Prevention of Age-Related Macular Degeneration |
| title_short | Diagnosis, Treatment and Prevention of Age-Related Macular Degeneration |
| title_sort | diagnosis treatment and prevention of age related macular degeneration |
| topic | aflibercept monotherapy polypoidal choroidal vasculopathy neovascular age-related macular degeneration good baseline visual acuity ForeseeHome AMD Monitoring System® AREDS2-HOME study age-related macular degeneration exudation optical coherence tomography angiography anti-vascular endothelial growth factor brolucizumab epithelial tear optical coherence tomography Sorsby’s fundus dystrophy Sorsby hereditary retinal dystrophy choroidal neovascularisation macular neovascularization anti-VEGF treatment long-term FU treatment outcome emerging treatment neovascular age-related macular degeneration (nAMD) Vascular Endothelial Growth Factor (VEGF) cataract surgery clinical trials real-world evidence AMD oct-angiography fellow eye choriocapillaris quiescent macular neovascularization ranibizumab aflibercept anti-VEGF visual acuity reading acuity disease activity treatment change treat and extend switch therapy retina choroidal neovascularization angiogenesis meteorin therapeutic innovation prevention nutrients lifestyle treatment-naive anti–vascular endothelial growth factor cardiovascular risk factors arterial hypertension macula-off rhegmatogenous detachment superficial perifoveal capillary plexus retinal deep perifoveal capillary plexus identification risk Delphi STARS® food supplement bevacizumab meta-analysis meta-regression n/a age-related macular degeneration (AMD) comparative therapies effectiveness intravitreal anti-vascular endothelial growth factor treat-and-extend pro re nata regimen thema EDItEUR::M Medicine and Nursing |
| topic_facet | aflibercept monotherapy polypoidal choroidal vasculopathy neovascular age-related macular degeneration good baseline visual acuity ForeseeHome AMD Monitoring System® AREDS2-HOME study age-related macular degeneration exudation optical coherence tomography angiography anti-vascular endothelial growth factor brolucizumab epithelial tear optical coherence tomography Sorsby’s fundus dystrophy Sorsby hereditary retinal dystrophy choroidal neovascularisation macular neovascularization anti-VEGF treatment long-term FU treatment outcome emerging treatment neovascular age-related macular degeneration (nAMD) Vascular Endothelial Growth Factor (VEGF) cataract surgery clinical trials real-world evidence AMD oct-angiography fellow eye choriocapillaris quiescent macular neovascularization ranibizumab aflibercept anti-VEGF visual acuity reading acuity disease activity treatment change treat and extend switch therapy retina choroidal neovascularization angiogenesis meteorin therapeutic innovation prevention nutrients lifestyle treatment-naive anti–vascular endothelial growth factor cardiovascular risk factors arterial hypertension macula-off rhegmatogenous detachment superficial perifoveal capillary plexus retinal deep perifoveal capillary plexus identification risk Delphi STARS® food supplement bevacizumab meta-analysis meta-regression n/a age-related macular degeneration (AMD) comparative therapies effectiveness intravitreal anti-vascular endothelial growth factor treat-and-extend pro re nata regimen thema EDItEUR::M Medicine and Nursing |
| url | ONIX_20220506_9783036539300_71 |